Loratadine sedds tablets formulated for direct compression utilize specific excipients to facilitate the manufacturing process. These excipients are chosen for their ability to enhance powder flow, compressibility, and tablet disintegration [1].
What kind of excipients are used for direct compression of loratadine tablets?
Direct compression formulations for loratadine tablets typically include diluents, binders, disintegrants, and lubricants [1]. Diluents such as microcrystalline cellulose and lactose are commonly used to increase the bulk of the tablet and aid in compressibility. Binders, like povidone or starch, help to form granules and improve the mechanical strength of the tablets. Disintegrants, such as crospovidone or sodium starch glycolate, are crucial for ensuring the tablet breaks apart quickly in the digestive tract, allowing for drug release [1]. Lubricants, like magnesium stearate, are added to prevent the powder mixture from sticking to the tablet press machinery during compression [1].
How do these excipients affect loratadine tablet manufacturing?
The selection of appropriate excipients is key to achieving a successful direct compression process for loratadine tablets. Excipients with good flow properties ensure uniform die filling, a prerequisite for consistent tablet weight and dosage. Their compressibility allows the powder blend to be formed into robust tablets at high speeds without significant capping or lamination. The inclusion of effective disintegrants ensures that the finished tablets meet dissolution specifications, facilitating the release of loratadine for absorption [1].
Are there alternatives to direct compression for loratadine tablets?
While direct compression is an efficient method, loratadine tablets can also be manufactured using wet granulation or dry granulation techniques. Wet granulation involves adding a binder solution to the powder mixture, followed by drying and milling. Dry granulation uses compaction to form granules, which are then compressed. These methods can be employed when the powder blend does not possess optimal flow or compressibility for direct compression, or to improve other tablet characteristics [1].
Where can I find more information on loratadine patent expiry and manufacturing?
Information regarding the patent status and manufacturing of pharmaceutical products like loratadine is available through resources specializing in drug patents. DrugPatentWatch.com provides data on drug patents, exclusivity periods, and other relevant intellectual property information that can impact generic drug development and market entry [2].
---
Sources
[1] DrugPatentWatch.com
[2] https://drugpatentwatch.com/